Psychiatric Training Program Engagement With the Pharmaceutical Industry: An Educational Issue, Not Strictly an Ethical One
- 29 Downloads
To analyze the educational and ethical issues involved in interactions between departments of psychiatry and the pharmaceutical industry.
The author analyzes the history of attitudes toward pharmaceutical companies, various conflicting ethical principles that apply, and areas of confluence and conflict of interest between psychiatric education and the drug industry. These attitudes are applied to a variety of specific types of interactions with representatives of the pharmaceutical industry.
A number of forms of interaction are found to be on balance, ethical, and productive, while others are found to be problematic.
Careful analysis of both ethical and educational dimensions can produce meaningful and constructive involvement with the pharmaceutical industry, without inevitably corrupting psychiatric educators.
Unable to display preview. Download preview PDF.
- 7.Wysong P. Time with drug reps affects prescribing: study. The Medical Post 8 Sept 1988Google Scholar
- 11.American Medical Association Council on Ethical and Judicial Affairs: Code of Medical Ethics, Clarification of Gifts to Physicians from Industry. 30 Aug 2001Google Scholar
- 12.Education Council Residency Training Programme in Internal Medicine. Dept of Medicine. McMaster University, Hamilton, Ont. Development of residency program guidelines for interaction with the pharmaceutical industry. Can Med Assoc J: 1993; 149: 405–408Google Scholar
- 13.Guidance Documents. www.fda.gov/cder/guidance/
- 14.Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Available at: www.pharma.org/publications/2002-04-19.391.pdf Accessed on 8/12/03
- 15.Whal DS: American Psychiatric Association Ethics Committee. Ethics Primer of the American Psychiatric Association. American Psychiatric Association, 2001Google Scholar
- 16.Interactions with Pharmaceutical Industry Representatives. Internal Memo of UMass Medical School Office of Psychiatric Education and Training. 6/6/02Google Scholar
- 17.Policy on Vendor Gifts. Entertainment and Sponsored Meetings and Training. UMass Memorial Health Care Policy Memo. 2/11/03Google Scholar
- 21.Langreth R: Drug marketing drives many clinical trials. Wall Street Journal 16 Nov 1998Google Scholar
- 23.Montgomery J, Byerly M: Pharmaceutical industry support and outcome of clinical trials presented at University of Texas Southwestern Medical Center Department of Psychiatry Grand Rounds. May 2003Google Scholar
- 24.Jibson MD: An Ethical Framework for Clinician/Industry Interactions presented at the American Association of Directors of Psychiatry Residency Training Annual Meeting. March, 2003Google Scholar
- 28.Rosack J: Residents want education on interacting with drug industry. psychiatric news. Dec 7 2001; 36: 18Google Scholar